Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples